SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001654954-24-007246 from ENDRA Life Sciences Inc. (NDRA) (CIK 0001681682) (NDRA)

ENDRA Life Sciences Inc. (NDRA) (CIK 0001681682)
Date: June 3, 2024 · CIK: 0001681682 · Accession: 0001654954-24-007246

AI Filing Summary & Sentiment

File numbers found in text: 333-278842

Date
June 3, 2024
Author
CRAIG-HALLUM CAPITAL GROUP, LLC
Form
CORRESP
Company
ENDRA Life Sciences Inc. (NDRA) (CIK 0001681682)

Letter

Re:

ndra_corresp.htm

June 3, 2024

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

ENDRA Life Sciences Inc.

Registration Statement on Form S-1 (Registration No. 333-278842) -

Concurrence in Acceleration Request

Ladies and Gentlemen:

Craig-Hallum Capital Group, LLC (the “Placement Agent”), acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-278842) (the “Registration Statement”), hereby concurs in the request by ENDRA Life Sciences Inc. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Tuesday, June 4, 2024, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. The Placement Agent affirms that they are aware of their obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very truly yours,
CRAIG-HALLUM CAPITAL GROUP, LLC

Show Raw Text
CORRESP
1
filename1.htm

ndra_corresp.htm

  June 3, 2024

 VIA FACSIMILE AND EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporate Finance

 Washington, DC  20549

   Re:

   ENDRA Life Sciences Inc.

   Registration Statement on Form S-1 (Registration No. 333-278842) -

   Concurrence in Acceleration Request

 Ladies and Gentlemen:

 Craig-Hallum Capital Group, LLC (the “Placement Agent”), acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-278842) (the “Registration Statement”), hereby concurs in the request by ENDRA Life Sciences Inc. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Tuesday, June 4, 2024, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act.  The Placement Agent affirms that they are aware of their obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

   Very truly yours,

   CRAIG-HALLUM CAPITAL GROUP, LLC

   By:

   /s/ Rick Hartfiel

   Name:

   Rick Hartfiel,

   Title:

   Head of Investment Banking